EDWARD AUEN: Open Payments
NPI 1962464602 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 15 payments from 9 companies in 2025. Trend: 2023 $377 · 2024 $419 · 2025 $394
Food & beverage: $349Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Lilly USA, LLC | 1 | $45 |
| Verity Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Abbott Laboratories | 1 | $16 |
Products named: Ozempic, JARDIANCE, Kerendia, Tlando, GEMTESA, WATCHMAN FLX, SHINGRIX, FREESTYLE LIBRE 3.
Industry payments across CA — which companies pay providers there.
